Brighthouse Financial, Inc. (BHF)

Executive Summary / Key Takeaways

• Merger Arbitrage with Strategic Implications: Aquarian Capital's $70 per share all-cash acquisition, approved by shareholders in February 2026, values BHF at 0.51x book value and 10.5x earnings, representing a 17% premium to recent trading prices but likely undervaluing the company's transformed capital efficiency and market-leading Shield annuity franchise.

• Capital Efficiency Revolution Through Hedging Separation: BHF's strategic pivot to standalone hedging for new Shield business (completed Q4 2024) and its ongoing separation of legacy VA/Shield blocks by September 2025 addresses the 2024 statutory results, with management targeting reduced earnings volatility and improved RBC ratio stability within their 400-450% target range.

• Shield Annuity Moat Drives Durable Growth: Record $7.7 billion in 2024 Shield sales (12% growth) and 30% of total annuity account value demonstrate BHF's dominant position in the registered index-linked annuity (RILA) market, a product category benefiting from demographic tailwinds and rising demand for protected accumulation, though this concentration also introduces product-specific risk.

• Statutory Framework Masks Underlying Cash Generation: The company's preliminary 456% RBC ratio at year-end 2025, achieved without holding company capital contributions, combined with over $900 million in holding company liquid assets, suggests statutory accounting for variable annuities obscures genuine capital generation capability that a private buyer could unlock.

• Execution Risk Defines Asymmetric Outcomes: The investment thesis hinges on two variables: successful completion of the hedging strategy transition by September 2025 to reduce volatility, and management's ability to maintain pricing discipline amid intense competition from scale players like Corebridge Financial (CRBG) and Prudential (PRU), with failure potentially justifying the discounted takeout price.

Setting the Scene: A 162-Year-Old Insurer Reborn as a Capital Efficiency Play

Brighthouse Financial, founded in 1863 and headquartered in Charlotte, North Carolina, generates earnings through two primary engines: manufacturing and distributing annuity products that provide tax-deferred wealth accumulation and income security, and underwriting life insurance policies for wealth transfer and financial protection. The company sits at a critical inflection point, having spent eight years as an independent public company since its 2017 separation from MetLife (MET), during which it returned capital through $2.6 billion in share repurchases that reduced shares outstanding by 52%.

This capital return story masks a deeper strategic transformation. BHF operates in a competitive insurance landscape where scale players like Prudential and MetLife leverage global diversification and massive distribution networks, while specialized competitors like Corebridge Financial dominate through volume—CRBG's $42 billion in 2025 annuity sales exceed BHF's $10 billion. BHF's differentiation lies in product innovation, specifically its Shield Level Annuities, which now represent 30% of total annuity account value and have established the company as a market leader in the registered index-linked annuity (RILA) category.

The significance lies in the RILA market addressing a structural shift in retirement planning: aging demographics and the decline of defined benefit pensions have created sustained demand for products offering downside protection with upside potential. BHF's Shield products, which allow customers to participate in equity market gains while limiting losses, directly capture this trend. However, the company's mid-tier market position—ranking 16th in U.S. annuity sales—means it lacks the cost advantages of larger competitors, making capital efficiency and product-specific moats critical to sustaining profitability.

The company's history as a MetLife spin-off carries both advantages and legacy obligations. The 2005 acquisition of Travelers' long-term care block through its former parent integrated significant legacy liabilities that now reside in the Run-off segment, while the separation in 2017 gave management freedom to focus exclusively on U.S. life and annuities. This legacy burden explains why BHF maintains a dedicated Run-off segment managing universal life with secondary guarantees (ULSG) and structured settlements, a structural complexity that larger peers have either avoided or diversified away from. The Run-off segment's $436 million adjusted earnings in 2025, swinging from $65 million in 2024, demonstrates how actuarial assumption changes can create dramatic earnings volatility—precisely what the current hedging strategy overhaul aims to address.

Technology, Products, and Strategic Differentiation: The Shield Platform and Hedging Revolution

BHF's core competitive advantage resides in its Shield annuity platform, an index-linked product architecture that delivers protected wealth accumulation with customizable risk profiles. Unlike traditional variable annuities that expose insurers to significant market risk through guaranteed minimum benefits, Shield products incorporate explicit hedging mechanisms that BHF has now fully transitioned to a standalone basis for all new business as of year-end 2024. This technical achievement fundamentally alters the risk-return profile of new sales, reducing capital strain and earnings volatility while maintaining the product's appeal to risk-averse retirees.

The hedging strategy evolution represents BHF's most important operational initiative. Management recognized that managing variable annuity (VA) and first-generation Shield blocks as a combined entity created complexity that contributed to 2024 statutory results. By separating these blocks and implementing distinct hedging strategies—targeting completion by September 2025—BHF aims to introduce more transparency and allow for more effective management. This separation directly addresses the $300 million decline in Total Adjusted Capital (TAC) experienced in Q4 2024 due to interest rate movements and the $200 million increase in asset adequacy testing reserves on legacy fixed annuity blocks.

This matters because the hedging transition transforms BHF from a company whose earnings are sensitive to equity market movements and actuarial model refinements into one with more predictable, hedgeable risk exposures. The 2025 statutory Annual Actuarial Review (AAR) that increased the long-term general account earned rate from 4% to 4.50% for ULSG business, resulting in a $359 million liability decrease, demonstrates how assumption changes can create capital benefits once the hedging framework is properly aligned. More importantly, management's explicit statement that they maintain a "maximum loss tolerance of up to $500 million on a statutory basis" relative to CTE98 provides a clear risk boundary that institutional investors can model.

Product innovation extends beyond Shield. The 2023 launch of Brighthouse SmartGuard Plus, an index-linked universal life product with a guaranteed distribution rider, and the 2024 enhancements to SmartCare demonstrate BHF's ability to iterate on its core technology platform. The partnership with BlackRock (BLK) for LifePath Paycheck (LPP), which received $176 million in deposits in Q2 2025 and is now live in six employer retirement plans with $16 billion in AUM, represents a strategic push into the worksite channel. This diversifies distribution beyond the independent advisor network, potentially reducing customer acquisition costs and tapping into the projected annuity market through institutional partnerships.

However, BHF's technology moat faces competitive pressure. While management claims a market leader position in the RILA marketplace, they acknowledge intense competition. Corebridge Financial's record $42 billion in annuity sales and Prudential's top-five market position create pricing pressure that BHF counters through pricing discipline maintained for eight years. This discipline, while protecting margins, may limit market share gains in a volume-driven industry where scale directly impacts cost of capital and reinsurance availability.

Financial Performance & Segment Dynamics: Capital Generation vs. Statutory Volatility

BHF's consolidated financial results show growth alongside statutory accounting complexity. Total revenues reached $6.21 billion on a trailing twelve-month basis, with the Annuities segment generating $3.64 billion in 2025 revenues, up from $1.93 billion in 2024. This increase reflects both growth in account values and market-driven changes in benefit reserves. Adjusted earnings for 2025 reached $1.60 billion, up $298 million, driven by lower net costs from insurance-related activities after the AAR and higher net fee income from reduced cost of insurance (COI) fee ceding.

The segment dynamics reveal the true earnings drivers. Annuities generated $1.25 billion in adjusted earnings with deposits of $8.7 billion in 2025, including Shield annuities of $8.0 billion. This represents a 4% increase in total annuity deposits year-over-year, but the mix shift toward Shield products increases capital strain. Management explicitly quantified this impact, noting that Shield strain accounted for approximately 35 points of the decline in the RBC ratio year-to-date, with the ratio falling 45-65 points overall. This explains why a growing franchise can simultaneously consume capital, creating tension between sales growth and capital efficiency.

The Life segment demonstrates steady execution with $1.15 billion in revenues and $41 million in adjusted earnings. Record sales of $120 million in 2024 (18% growth) and $69 million year-to-date through Q2 2025 (21% growth) show consistent momentum, but the segment's profitability reflects BHF's strategic choice to prioritize design and profitability over sales volume in universal life products. This contrasts with competitors like Lincoln National (LNC), whose life insurance rebound drove 31% earnings growth, suggesting BHF's conservative approach may be prioritizing margin stability over market share.

The Run-off segment's volatility underscores the statutory accounting challenge. The segment swung from $65 million in adjusted earnings in 2024 to $436 million in 2025, primarily due to the $359 million ULSG liability decrease from the AAR. However, this same segment contributed to the Q4 2024 TAC decline through model refinements and interest rate impacts. The 2024 AAR's $570 million after-tax impact, driven by a 25 basis point increase in the 10-year Treasury mean reversion rate, demonstrates how sensitive legacy blocks are to assumption changes—a risk BHF is actively reinsuring away through transactions like the Q4 2024 universal life and VUL block reinsurance.

Capital management remains central to the thesis. BHF's preliminary combined RBC ratio of 456% at December 31, 2025 sits above the 400-450% target range, achieved without holding company contributions after the $100 million injection in Q4 2024. Holding company liquid assets of over $900 million provide strategic flexibility, though the merger agreement now prohibits share repurchases without Aquarian's consent. The company repurchased $102 million of common stock year-to-date through Q2 2025, continuing a program that has retired 52% of shares since 2018.

Outlook, Management Guidance, and Execution Risk

Management's guidance frames 2025 as a transition year focused on completing strategic initiatives. The hedging strategy revision for legacy VA and first-generation Shield blocks, expected by September 2025, represents the critical path item. Management has stated that these initiatives must be completed before providing an outlook for future results, signaling that current earnings volatility is temporary, though investors must wait for proof that the new hedging framework delivers stability.

The merger timeline adds urgency. With shareholder approval secured in February 2026 and closing expected in 2026, the window for the standalone thesis is limited. The $70 per share price represents a 17% premium to recent trading levels but values the company at 0.51x book value, compared to peers like Prudential at 1.0x and MetLife at 1.56x. This valuation gap suggests Aquarian Capital sees opportunity to unlock value through private market mechanisms, potentially by accelerating capital release from the hedging transformation.

Management's commentary on flows provides insight into underlying business health. Expectations for flows to be at the 2024 level or higher indicate that despite outflows from Shield and VA products exiting surrender charge periods, new sales are offsetting redemptions. The Q2 2025 sequential increase in Shield sales to $1.9 billion, bringing year-to-date to $3.9 billion, demonstrates that pricing discipline is maintaining market position even as competition intensifies.

The expense management narrative supports margin stability. Full-year 2024 corporate expenses declined over 7% compared to 2023, with management maintaining strict expense discipline. Q1 2025's elevated $239 million in corporate expenses was deemed non-trendable, which Q2's decline to $202 million confirmed. This cost control is essential for BHF to maintain its competitive status against larger competitors with scale advantages.

Alternative investment income volatility remains a key factor. Q2 2025's 1.5% yield versus the 9-11% long-term expectation created a $60 million shortfall versus run-rate expectations. This quarterly variance from alternatives can impact results, making the hedging strategy's ability to isolate core earnings from market noise even more critical for predictable capital generation.

Risks and Asymmetries: Where the Thesis Can Break

The merger itself presents the most immediate risk. The $144 million termination fee if BHF accepts a superior offer, combined with restrictions on strategic transactions, effectively locks in the $70 price unless a competing bid emerges. While the low valuation multiple suggests strategic buyers or private equity could justify higher bids, the merger agreement structure deters interlopers.

Hedging strategy execution risk defines the standalone value proposition. Management's commitment to a maximum loss tolerance of up to $500 million on a statutory basis provides a clear risk boundary, but the complexity of separating VA and Shield blocks introduces model risk. If the revised hedging strategy fails to reduce volatility or creates unexpected capital charges, the statutory framework could further deteriorate, validating the discounted takeout price.

Regulatory changes pose material threats. The NAIC's AI governance model bulletin creates uncertainty around underwriting and pricing practices. More significantly, changes to RBC market risk requirements under the Valuation Manual could negatively impact statutory surplus and required capital. The Corporate Alternative Minimum Tax (CAMT) remains an uncertainty, which could reduce post-tax capital generation available for dividends or buybacks.

Competitive dynamics create margin pressure. Corebridge Financial's $42 billion in annuity sales and Prudential's top-tier positioning mean BHF's pricing discipline could cede market share. The RILA market's growth attracts new entrants, and BHF's reliance on independent advisors versus proprietary distribution creates vulnerability if larger competitors bundle annuities with other financial products.

The Run-off segment's legacy liabilities remain a latent risk. While reinsurance transactions have reduced exposure, the ULSG block's sensitivity to interest rate assumptions means a reversal of the 2025 AAR benefit could create statutory capital volatility. The $187 million loss in Q1 2024 from a reinsurance arbitration panel ruling demonstrates how legacy contracts can produce sudden, material charges.

Valuation Context: The Merger Price vs. Intrinsic Value

Trading at $59.98 per share, BHF trades at a discount to the $70 merger price, implying a 17% spread that reflects market skepticism about deal completion or the valuation. The current valuation metrics reveal why Aquarian Capital's bid looks opportunistic:

• Price-to-Book: 0.51x versus Prudential at 1.0x, MetLife at 1.56x, and Lincoln National at 0.65x. This discount to peers suggests the market assigns a conglomerate discount to BHF's structure, despite the Shield franchise's market leadership.

• Price-to-Earnings: 10.5x versus Prudential at 9.34x and Lincoln at 5.86x. While not dramatically cheap on earnings, this multiple may understate true economic earnings due to statutory accounting noise.

• Enterprise Value-to-Revenue: 0.94x, higher than Prudential's 0.59x but below MetLife's 1.12x, reflecting BHF's higher revenue growth but lower profitability margins.

• Return on Equity: 7.39% lags Prudential's 11.36% and MetLife's 12.02%, but this gap should narrow as the hedging strategy reduces volatility and unlocks trapped capital.

The merger valuation of $4.1 billion represents approximately 0.66x TTM revenue and 9.5x TTM net income, multiples that are relatively low for a growing annuity franchise with improving capital efficiency. The price implies Aquarian Capital believes it can extract value through either breaking up the company or optimizing the capital structure in ways public market constraints prevented.

Conclusion: A Transforming Franchise Caught in Value Transfer

Brighthouse Financial's investment thesis centers on a capital efficiency transformation that the market has not fully recognized, creating an opportunity for Aquarian Capital to acquire a market-leading RILA franchise at a distressed valuation. The company's record Shield annuity sales, disciplined expense management, and strategic hedging separation position it to generate more stable statutory earnings and unlock trapped capital, yet the stock trades at a discount to peer multiples.

The merger at $70 per share represents a premium to recent trading but likely undervalues the transformed business model that will emerge post-hedging completion in September 2025. For investors, the outcomes are clear: successful hedging execution and continued Shield growth could support higher valuations, while failure would validate the discounted takeout as the best outcome.

The critical variables to monitor are the September 2025 hedging transition completion and management's ability to maintain pricing discipline in an increasingly competitive RILA market dominated by scale players. With shareholder approval secured and regulatory review pending, the merger timeline compresses the investment decision: either accept the 17% spread as merger arbitrage, or recognize that private market buyers see value the public market missed.